http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102503903-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
filingDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe7690226487b9664dd4ecadc3d1f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65d706d6c2bccfdb058d33363f19d852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e071adfab5cbd68f3583332c84ed00f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66d07b0d86c47b594a8db0dc313d050
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef12f4d26f416d6627281f79828b5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11cf3089783b785732bbd1533c523670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f99b0aa37410b2ce6bf89bbd2f9b1a19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dd1e512ed6c32d80f723f54faafb1c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80bc4e07cc6148638f13b480b77b3c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2eb14ccea385b377686a538d3a2e73c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35061686b482f41200cad6b7bc1dc802
publicationDate 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102503903-A
titleOfInvention HIV inhibiting 1,2,4-triazines
abstract The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
priorityDate 2003-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467528071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57837234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467929449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407924367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70967396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465918534

Total number of triples: 36.